Ireland· IE-PA-PA1445/018/001

Alfu 10 mg Prolonged-release Tablets

A alfuzosin product containing alfuzosin hydrochloride, registered in Ireland by Aurobindo Pharma (Malta) Limited. The same ATC class is registered in 18 of our 19 countries.

ATC G04CA01

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about alfuzosin hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Alfuzosin is registered in 18 of 19 countries.

Countries holding a registration under ATC G04CA01 (alfuzosin), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
11 of them publish a price we can compare per daily dose

Search alfuzosin products by name

Alfuzosin · ATC G04CA01

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alfuzosin costs, country by country.

Normalised to the WHO defined daily dose (7.5 mg), the median price runs from $0.25 in France to $0.93 in Switzerland — a ×3.7 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Alfuzosin · price per daily dose (7.5 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.93
ES Spain$0.34
IT Italy$0.25
FR France$0.25

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Alfuzosin hydrochloride
Manufacturer: Aurobindo Pharma (Malta) Limited
Country: Ireland (IE)
ATC code: G04CA01
ATC class: Alfuzosin
Defined daily dose: 7.5 mg, O
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA1445/018/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

330 interactions on record for alfuzosin.

Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check alfuzosin against other medicines How interaction checks work

Alfuzosin · interactions on record

330 records

47 severe
182 moderate
3 minor
48 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
PapaverinC04AX38severe

50 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alfuzosin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alfuzosin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Alfuzosin Stada
Belgium · Alfuzosine Sandoz, Xatral Retard
Cyprus · Alfural, Alfuzosin Aurobindo
Czechia · Alfuzosin Viatris
Germany · Alfuzosin, Alfuzosin 10 1 A Pharma
Denmark · Alfuzosin Orion, Alfuzosin Sandoz
Estonia · Alfuzosin Teva, Xatral Sr
Spain · Alfuzosina Aurovitas, Alfuzosina Stada
Finland · Alfuzosin Hydrochlorid Ratiopharm, Alfuzosin Hydrochloride Orion
France · Alfuzosine, Alfuzosine L.P Eg
United Kingdom (Northern Ireland) · Alfuzosin Hcl Milpharm, Alfuzosin Hydrochloride Teva Uk
Greece · Alcinin, Alfudex
Hungary · Alfetim Sr, Alfetim Uno
Iceland · Alfuzosin Hydrochloride Alvogen
Italy · Alfuzosin Ratiopharm, Alfuzosina Aurobindo
Lithuania · Xatral Sr
Luxembourg · Xatral Uno
Latvia · Alfuzosin Teva, Xatral Sr
Malta · Zochek
Netherlands · Alfuzosine Hcl Aurobindo, Alfuzosine Hcl Cf
Poland · Alfabax, Alfurion
Portugal · Alfuzosin Teva, Alfuzosina Aurovitas
Romania · Xatral Sr
Sweden · Alfuzosin Orion, Alfuzosin Rivopharm
Slovakia · Alfuzosin Sandoz, Alfuzosin Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c2e42bce-40a7-43b1-af7d-ad8e22e63167
GET /v1/drugs/c2e42bce-40a7-43b1-af7d-ad8e22e63167?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prolonged-release tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "G04CA",
    "G04CA01"
  ],
  "strength": null,
  "pa_number": "PA1445/018/001",
  "substances": [
    "Alfuzosin hydrochloride"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "08/08/2014",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about alfuzosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console